spinout
The expansion is one of several updates on the DNA synthesis firm's plans for its fiscal year 2022, which began last month.
The Bruker-backed startup will make technology whose data could be complementary to both NGS-based Hi-C assays and spatial transcriptomics methods.
The RT-LAMP-based platform, which the researchers plan to commercialize through a spinout company, could be adapted for other infectious disease tests.
At the ASHG 2020 virtual meeting, researchers presented data showing they could use the method to enrich for placental DNA in maternal plasma samples.
Tiziana Life Sciences to Spin Off StemPrintER Asset Into Separate Company
The company, which originally announced plans for a possible spin off in June, will hold a shareholder meeting to vote on the details in October.
Jul 27, 2020
Jan 29, 2020
IDbyDNA Raises $20M in Series B Financing
Dec 10, 2019
Enzo Biochem Fiscal Q1 Revenues Down 5 Percent
Jul 24, 2019
Mar 28, 2019
Jun 19, 2018
Sep 6, 2017
Jun 2, 2017